1. Home
  2. Documents
  3. COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021—April 2022: A test negative design

COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021—April 2022: A test negative design

im-revelac-ve-covid-19-2021-22-pry-en
https://doi.org/10.1016/j.vaccine.2023.09.015

This study contributes to our understanding of COVID-19 VE in Latin America and to global understanding of vaccines that have not been widely used in North America and Europe. VE estimates from Paraguay can parameterize models to estimate the impact of the national COVID-19 vaccination campaign in Paraguay and similar settings.

Sandra Irala, Sarah Hamid, Elena Penayo, Fabiana Michel, Paula Couto, Cynthia Vazquez, María José Ortega, Chavely Domínguez, Silvia Battaglia, Marta Von Horoch, Romeo Montoya, Guillermo Sequera, Francisco Nogareda, COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021—April 2022: A test-negative design, Vaccine, 2023, , ISSN 0264-410X, https://doi.org/10.1016/j.vaccine.2023.09.015. (https://www.sciencedirect.com/science/article/pii/S0264410X23010691)